StockViz
RANKINGS
Ultragenyx Pharmaceutical Inc.
NasdaqGS:RARE
Sector
Industries
Location
Market Cap
USD 2.49 B
Share Price
USD 26.39
Avg Daily Volume
1,069,410
Change (1 day)
0.30%
Change (1 year)
-37.98%
Change (YTD)
-37.27%
Ultragenyx Pharmaceutical Inc. Key Metrics 2015 - 2025
This table shows the Key Metrics for Ultragenyx Pharmaceutical Inc. going from 2015 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Thermo Fisher Scientific Inc.
USD 404.94
TMO
-9.81
-2.37%
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Siemens Healthineers AG
USD 53.54
SHL.DE
-0.07
-0.12%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%